Skip to content
Screener

Champions Oncology CSBR Q2 2026 Annual earnings

Reported July 27, 2026 · After market close

Revenue$13.8MBeat by $949.0K
EPS$0.01Beat by $0.06
Revenue estimate$12.9M
EPS estimate-$0.05

Next report

Sep 14, 2026 (In 2 weeks)
Revenue estimate$15.0M
EPS estimate-$0.01

FAQ

When did Champions Oncology report Q2 2026 earnings?
Champions Oncology (CSBR) reported Q2 2026 earnings on July 27, 2026 after market close.
What were Champions Oncology's Q2 2026 revenue and EPS?
Champions Oncology reported revenue of $13.8M and eps of $0.01 for Q2 2026.
Did Champions Oncology beat estimates in Q2 2026?
Revenue beat the consensus estimate of $12.9M by $949.0K. EPS beat the consensus estimate of $-0.05 by $0.06.
How did Champions Oncology's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.0% from $12.4M a year earlier.
Where can I find Champions Oncology's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-049822) and the 10-K periodic report (0001628280-26-049834) directly on SEC EDGAR. The filing index links above go to sec.gov.